Intra-articular chromic phosphate (32P) in the treatment of diffuse pigmented villonodular synovitis

Jennifer E. Zook, Daniel L. Wurtz, Judd E. Cummings, Higinia R. Cárdenes

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: Pigmented villonodular synovitis (PVNS) is an uncommon proliferative lesion of synovial tissue. In diffuse PVNS, recurrence rates are high after resection alone. Adjuvant external beam radiation therapy contributes to improved local control. Limited data exist for intra-articular radioisotope therapy after surgical resection. We report institutional experience with intra-articular chromic phosphate (32P). Methods and Materials: Records were reviewed from the Department of Radiation Oncology at Indiana University. Nine cases of PVNS treated with 32P were identified (mean age=40). Seven patients were treated at time of recurrence and 2 patients were treated prophylactically. Intra-articular injections were performed by accessing the joint space, aspirating joint fluid, reinjecting 1-2mCi of 32P, and barbitaging to ensure good distribution in the joint space. No external beam radiation therapy was delivered. One patient was lost to followup. Mean followup of remaining patients was 20 months (range, 2-48). Results: Eleven injections were performed in 9 patients. Eight had PVNS in the knee(s) and 1 patient had involvement of the hip. Two patients were treated more than once, one for a recurrence in the same joint at 13 months and another for PVNS of a contralateral joint. Three clinical recurrences (2, 13, and 28 months) were noted. Two of three recurrences were in patients who had bulky diffuse PVNS at the time of injection. Overall local control was 70%. In patients without bulky diffuse PVNS at the time of injection, local control was 88%. Conclusion: We report success using intra-articular injections of 32P after synovectomy in patients with PVNS.

Original languageEnglish (US)
Pages (from-to)190-194
Number of pages5
JournalBrachytherapy
Volume10
Issue number3
DOIs
StatePublished - May 1 2011

Fingerprint

Pigmented Villonodular Synovitis
Joints
Recurrence
Therapeutics
Intra-Articular Injections
Injections
Radiotherapy
chromic phosphate
Radiation Oncology
Radioisotopes
Hip
Knee

Keywords

  • Benign disease
  • Chromic phosphate
  • Intra-articular
  • Pigmented villonodular synovitis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Intra-articular chromic phosphate (32P) in the treatment of diffuse pigmented villonodular synovitis. / Zook, Jennifer E.; Wurtz, Daniel L.; Cummings, Judd E.; Cárdenes, Higinia R.

In: Brachytherapy, Vol. 10, No. 3, 01.05.2011, p. 190-194.

Research output: Contribution to journalArticle

Zook, Jennifer E. ; Wurtz, Daniel L. ; Cummings, Judd E. ; Cárdenes, Higinia R. / Intra-articular chromic phosphate (32P) in the treatment of diffuse pigmented villonodular synovitis. In: Brachytherapy. 2011 ; Vol. 10, No. 3. pp. 190-194.
@article{39448860aac6472dbda1bf46a01e6739,
title = "Intra-articular chromic phosphate (32P) in the treatment of diffuse pigmented villonodular synovitis",
abstract = "Purpose: Pigmented villonodular synovitis (PVNS) is an uncommon proliferative lesion of synovial tissue. In diffuse PVNS, recurrence rates are high after resection alone. Adjuvant external beam radiation therapy contributes to improved local control. Limited data exist for intra-articular radioisotope therapy after surgical resection. We report institutional experience with intra-articular chromic phosphate (32P). Methods and Materials: Records were reviewed from the Department of Radiation Oncology at Indiana University. Nine cases of PVNS treated with 32P were identified (mean age=40). Seven patients were treated at time of recurrence and 2 patients were treated prophylactically. Intra-articular injections were performed by accessing the joint space, aspirating joint fluid, reinjecting 1-2mCi of 32P, and barbitaging to ensure good distribution in the joint space. No external beam radiation therapy was delivered. One patient was lost to followup. Mean followup of remaining patients was 20 months (range, 2-48). Results: Eleven injections were performed in 9 patients. Eight had PVNS in the knee(s) and 1 patient had involvement of the hip. Two patients were treated more than once, one for a recurrence in the same joint at 13 months and another for PVNS of a contralateral joint. Three clinical recurrences (2, 13, and 28 months) were noted. Two of three recurrences were in patients who had bulky diffuse PVNS at the time of injection. Overall local control was 70{\%}. In patients without bulky diffuse PVNS at the time of injection, local control was 88{\%}. Conclusion: We report success using intra-articular injections of 32P after synovectomy in patients with PVNS.",
keywords = "Benign disease, Chromic phosphate, Intra-articular, Pigmented villonodular synovitis",
author = "Zook, {Jennifer E.} and Wurtz, {Daniel L.} and Cummings, {Judd E.} and C{\'a}rdenes, {Higinia R.}",
year = "2011",
month = "5",
day = "1",
doi = "10.1016/j.brachy.2010.05.006",
language = "English (US)",
volume = "10",
pages = "190--194",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Intra-articular chromic phosphate (32P) in the treatment of diffuse pigmented villonodular synovitis

AU - Zook, Jennifer E.

AU - Wurtz, Daniel L.

AU - Cummings, Judd E.

AU - Cárdenes, Higinia R.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Purpose: Pigmented villonodular synovitis (PVNS) is an uncommon proliferative lesion of synovial tissue. In diffuse PVNS, recurrence rates are high after resection alone. Adjuvant external beam radiation therapy contributes to improved local control. Limited data exist for intra-articular radioisotope therapy after surgical resection. We report institutional experience with intra-articular chromic phosphate (32P). Methods and Materials: Records were reviewed from the Department of Radiation Oncology at Indiana University. Nine cases of PVNS treated with 32P were identified (mean age=40). Seven patients were treated at time of recurrence and 2 patients were treated prophylactically. Intra-articular injections were performed by accessing the joint space, aspirating joint fluid, reinjecting 1-2mCi of 32P, and barbitaging to ensure good distribution in the joint space. No external beam radiation therapy was delivered. One patient was lost to followup. Mean followup of remaining patients was 20 months (range, 2-48). Results: Eleven injections were performed in 9 patients. Eight had PVNS in the knee(s) and 1 patient had involvement of the hip. Two patients were treated more than once, one for a recurrence in the same joint at 13 months and another for PVNS of a contralateral joint. Three clinical recurrences (2, 13, and 28 months) were noted. Two of three recurrences were in patients who had bulky diffuse PVNS at the time of injection. Overall local control was 70%. In patients without bulky diffuse PVNS at the time of injection, local control was 88%. Conclusion: We report success using intra-articular injections of 32P after synovectomy in patients with PVNS.

AB - Purpose: Pigmented villonodular synovitis (PVNS) is an uncommon proliferative lesion of synovial tissue. In diffuse PVNS, recurrence rates are high after resection alone. Adjuvant external beam radiation therapy contributes to improved local control. Limited data exist for intra-articular radioisotope therapy after surgical resection. We report institutional experience with intra-articular chromic phosphate (32P). Methods and Materials: Records were reviewed from the Department of Radiation Oncology at Indiana University. Nine cases of PVNS treated with 32P were identified (mean age=40). Seven patients were treated at time of recurrence and 2 patients were treated prophylactically. Intra-articular injections were performed by accessing the joint space, aspirating joint fluid, reinjecting 1-2mCi of 32P, and barbitaging to ensure good distribution in the joint space. No external beam radiation therapy was delivered. One patient was lost to followup. Mean followup of remaining patients was 20 months (range, 2-48). Results: Eleven injections were performed in 9 patients. Eight had PVNS in the knee(s) and 1 patient had involvement of the hip. Two patients were treated more than once, one for a recurrence in the same joint at 13 months and another for PVNS of a contralateral joint. Three clinical recurrences (2, 13, and 28 months) were noted. Two of three recurrences were in patients who had bulky diffuse PVNS at the time of injection. Overall local control was 70%. In patients without bulky diffuse PVNS at the time of injection, local control was 88%. Conclusion: We report success using intra-articular injections of 32P after synovectomy in patients with PVNS.

KW - Benign disease

KW - Chromic phosphate

KW - Intra-articular

KW - Pigmented villonodular synovitis

UR - http://www.scopus.com/inward/record.url?scp=79955135507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955135507&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2010.05.006

DO - 10.1016/j.brachy.2010.05.006

M3 - Article

C2 - 20685177

AN - SCOPUS:79955135507

VL - 10

SP - 190

EP - 194

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 3

ER -